Discussion and Q&A - Amsterdam 2025 - ERS Respiratory Channel

CDN Connection Issue

It appears that your current network does not allow connection to the CDN (Content Delivery Network) required for this service to function properly.

To resolve this issue, please try the following actions :

• Contact your network administrator : Inform them of this restriction so they can adjust the network settings accordingly.

• Use another network : Try connecting from a different network, such as another Wi-Fi network or a mobile connection.

We apologize for the inconvenience and thank you for your understanding.

International Congresses Amsterdam 2025 Discussion and Q&A

Chronic obstructive pulmonary disease and type 2 inflammation: is it really a treatable trait?

Chair(s): Francesca Polverino, Augusta Beech

Session type: Symposium

Discussion and Q&A

EVENTS HOME

Replay

Previous presentation

Next presentation

Session content

COPD: pathobiological features supporting the case for a T2 trait

Carlos Cabrera Lopez

Replay

Slides

Eosinophilic COPD: is it just asthma? Evidence from the clinic and trials

Johann Christian Virchow

Replay

Slides

Beyond eosinophils and T2: conventional culprits and targets in COPD biology

Hsiao-chi Chuang

Replay

Slides

Current and future therapeutic targets in COPD: insights from clinical trials

Mona Bafadhel

Replay

Slides

Discussion and Q&A

Replay

Session aims

to discuss the recent findings on type 2 (T2) inflammation in chronic obstructive pulmonary disease (COPD); to explore the future of therapeutic development of T2 immune modulators in COPD.

CDN Connection Issue

The ERS Congress 2025, Amsterdam

#{title}